Mkt Cap $114M
52-Week Range
Biodesix, Inc.
Revenue is primarily driven by Diagnostic Tests (90%) and Development Services (10%).
Most recently: to this Current Report on Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Ex (2026-02-26).
$114M
Market Cap
$83M
Revenue
-$33M
Net Income
Revenue by Segment